CD34+ population enumeration has multiple applications, for example to indicate whether a hematopoietic stem-cell harvest is ready to be performed for transplant, or to characterise progenitor/precursor populations such as B-cell precursors in Acute lymphoblastic leukaemia (ALL) samples. However, rare CD34+ …
Read MoreCategory: CTC
Stabilisation of Circulating Endothelial Progenitor Cells
TransFix stabilises lymphocytes for up to 14 days, but other cell populations have also been shown to be stable with TransFix. One example is Circulating Endothelial and Endothelial Progenitor Cells which have been referenced by multiple papers: TransFix for Delayed …
Read MorePreservation of mRNA from Isolated Circulating Tumour Cells
It is well documented that TransFix treated blood is compatible with isolation of circulating tumour cells, but new work published by Baird et al. describes a novel method of isolating CTCs, and the first published method of extracting mRNA from …
Read MoreTransFix Compatible Antibodies
TransFix is designed to stabilise TBNK surface markers for up to 14 days for flow cytometry analysis. Researchers around the world use TransFix to stabilise over 100 different cellular markers. Cytomark have compiled a list of cellular markers and their …
Read MoreImproved Stabilisation, Isolation, and Characterisation of Circulating Tumour Cells
A combination of technologies from French company ScreenCell and British company Cytomark has allowed for improved analysis of single circulating tumour cells. Circulating Tumour Cells The number of circulating tumour cell populations present in patient blood is very low, therefore …
Read More